PHIO Research and Charts

PHIO - Phio Pharmaceuticals Corp (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2026-02-10)

Last 1.12	Change ⇑ +0.22 (+0.00%)	Volume 160,779,609
	Open 1.41	High 1.48	Low 1.12

8EMA (Daily) 0.98	40EMA (Daily) 1.11	50EMA (Daily) 1.16	STO (Daily) 24.556	MACD Hist (Daily) 0.010
8EMA (Weekly) 1.101	40EMA (Weekly) 1.61	50EMA (Weekly) 1.69	STO (Weekly) 9.625	MACD Hist (Weekly) 0.025


Company Profile
Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.